60 Degrees Pharmaceuticals, Inc. (SXTP)
Develops drugs to prevent and treat infectious diseases like malaria and COVID-19.
$1.53-0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-71.2%
The outlook
SXTP is trading near its 52-week lows with mixed short-term momentum, though analyst targets average 142% above the current price, suggesting significant upside in their base case. The overall sentiment leans bearish, and the stock remains positioned toward the bottom of its annual range. Coverage appears limited relative to the target spread.
What’s behind the score
Price trendMixed vs its moving averages
52-week range4% of the way from its 52-week low to high
Price targetAvg target +142% vs current price
Market cap
$4.1M
52-wk high
$8.62
52-wk low
$1.22
50-day avg
$1.53
200-day avg
$2.84
Trailing P/E
—